Methodology: Effect of pretreatment by crude and n-Hexane extract of Nigella (10mg/kg body wt./day for 21 days) on streptozotocin (STZ, 50 mg/kg body wt. single dose i.p.) administered rats were observed in the present study. Biochemical parameters (Serum glucose, serum TG, serum cholesterol, pancreatic GSH) were compiled together with pancreatic histology. Results: Both the crude and the n-Hexane extract of Nigella pre-treated diabetic rats had demonstrated significant (P<0.001) alleviation from the elevated serum glucose, lowered pancreatic reduced glutathione (P<0.01) and elevated serum TG concentrations (P<0.01). 72% β cells appeared to be damaged by STZ administration, while in the crude and the n-Hexane extract of Nigella pretreated diabetic groups this damage was 31% and 46% respectively, the crude Nigella pretreated group thus appeared to have better amelioration. Conclusions: Further studies are suggested to obtain the protective ingredient from the crude Nigella and to observe its effect upon the above mentioned parameters of diabetic rats in higher doses for prolonged periods.
Introduction
From the time immemorial, varieties of herbals were used to alleviate different diseases of mankind. This study was an attempt to search for herbal remedies of diabetes mellitus, a disease which encircles disorders of carbohydrate, fat and protein metabolism in consequence of either absence of insulin or ineffective action of insulin; replacement of which may correct the blood sugar concentrations and reverse the metabolic disorders. Nigella sativa Linn. (Kalajira) is a widely used spice in Asia whose antimicrobial, antidiabetic, antitnephrotoxic and anti lipid properties have been reported 1, 2, 3, 4 . Streptozotocin (STZ) was used to induce diabetes in adult male rats. Crude Nigella and its n-hexane extract were administered into these rats from day 1 to day 10 and were continued up to day 21. STZ was administered on day 11. The aim was to observe whether the crude Nigella or its n-Hexane extract pre-treatment would be able to produce beneficiary effects upon the elevated serum glucose and elevated serum lipid (TG, cholesterol) levels and upon the lowered reduced glutathione levels along with alleviation of pancreatic β cell damage in diabetic rats.
Materials and methods
Animals: 52 adult male rats, Long Evans Norwegian strain, aged 8-12 weeks were obtained from the animal house of BSMMU and were kept in standard laboratory conditions. They were fed rat diet and given water ad libitum and rats were randomly divided into 6 groups.
Drug: Streptozotocin was obtained from Sigma Aldrich Cheme GmbH, Germany.
Test material: Nigella sativa Linn. (kalajira) was purchased from the local market.
Chemicals and reagents:
Reagents for the estimation of serum glucose, serum TG and serum cholesterol were purchased from Human, Germany. Chemicals for the estimation of pancreatic reduced glutathione (GSH) were purchased from Sigma Aldrich Cheme GmbH, Germany and chemicals required for histopathology from E. Merck, Germany.
The crude and the n-hexane extract of Nigella:
The seeds of Nigella were soaked in n-hexane for 48-72 hours. They were filtered and the filtrate was concentrated in a rotary vacuum evaporator. After evaporation a concentrated dark brown oily extract of Nigella was obtained. The left over seeds following filtration were obtained as the crude Nigella.
Experimental procedure: Normal rat diet and water ad libitum was allowed to control group of rats [group I(C)]. Rats of group II received single intraperitoneal injection of streptozotocin (STZ) 50mg/kg body weight in citrate buffer, pH 4.5 on day 11. Crude Nigella (10gm/kg body wt/day) dissolved in deionized water was administered through feeding tube to the rats of group III (Nc) for 21 days. Crude Nigella was administered from day 1 to day 21 while streptozotocin was administered on day 11 to rats of group IV (Nc+ STZ). The n-hexane extract of Nigella dissolved in deionized water was administered at the same dose as crude Nigella i.e. 10 gm/kg body wt. daily from day 1 to day 21 through Ryles tube to rats of group V (H). The n-hexane extract of Nigella was administered at 10 gm/kg body wt./day for 21 days while STZ was administered on day 11 intraperitoneally to rats of group VI (H+ STZ). All rats were sacrificed on Day 22. The rats were kept overnight fasting and only water was allowed to them and sacrifice was carried out under mild chloroform anesthesia and blood and the pancreas were collected from each rat. Serum was separated through centrifugation for biochemical analysis and the pancreatic tissue from each rat was processed separately for estimation of pancreatic GSH and histological study. The schedule of treatment and days of sacrifice has been presented on Table I . n= Number of rats in each group. C = Control, STZ = Streptozotocin, Nc = Crude Nigella, H = n-hexane extract of Nigella. 
Statistical analysis:
The results obtained from the experiment are expressed as mean ± SE of the number of samples. Data were analyzed by Students unpaired t-test. P<0.05 were taken as significant.
Results
Biochemical observations: Administration of streptozotocin on day 11 has caused significantly elevated (P<0.001) serum glucose, serum TG (P<0.01) and serum cholesterol levels (P<0.05) on day 22 (Table  II) . The pancreatic reduced glutathione concentrations (GSH) were significantly (P<0.001) lowered compared to those of the control values (Table II) . Treatment by crude Nigella alone (Nc) or by the n-hexane extract of Nigella (H) did not deviate the blood sugar concentrations from the control values, while serum TG and serum cholesterol concentrations were significantly (P<0.001) reduced; and the pancreatic reduced glutathione concentration was significantly (P<0.001) elevated. Blood sugar concentrations in the (Nc+ STZ) and (H+ STZ) groups were near to those of the control values. The serum TG in the (Nc+STZ) group and in the (H+STZ) group were lower (P<0.05 and P<0.01) compared to those of the STZ groups. Serum cholesterol concentration of the (Nc +STZ) and (H+STZ) groups remained at the level of the STZ group suggesting no alleviation in this parameter (Table II) . n= Number of rats in each group. C = Control, STZ = Streptozotocin, Nc = Crude Nigella, H = n-hexane extract of Nigella. NS indicates no significant difference; P< 0.001= ***, P<0.01=**, P<0.05=*.
Histological observations: In STZ-treated rats pancreatic sections stained with haematoxylin and eosin demonstrated degenerative and necrotic changes and shrunken islets of Langerhans. There was decrease (P<0.001) in the number of β cells (Fig-b) . Pretreatment by crude Nigella and by the n-hexane extract of Nigella, i.e. in the (Nc+STZ) and in the (H+STZ) groups, the severity of degenerative and necrotic changes in the islet of Langerhans appeared to be less (Fig d and f) . The number of the β cells were increased (P<0.01) and the islets appeared increased in size, compared to those of the STZ-treated group (Fig. b) . Lymphoid cell infiltration in the peripheral parts of the islets of Langerhans in sections from the STZ-treated rats was apparent, which appeared to be less in the (NC+STZ) and (H+STZ) groups (Fig. d & f) a) b) 
Discussion
The high serum glucose concentrations of the diabetic rats appeared to lower down towards control levels by pretreatment with the crude Nigella and with the n-hexane extract of Nigella and was in agreement with those obtained by Uddin et al. (2002) . The serum TG concentration was raised following STZ administration (P<0.001), however crude Nigella and n-hexane extract pretreatment brought them down to levels even lower compared to those in the control rats. This observation was similar to those obtained by Saha et al. (2004) when treatment with crude Nigella had lowered the serum TG concentrations of fat fed rats. The serum cholesterol concentrations of the crude and of the n-hexane extract of Nigella pretreated diabetic rats however, did not show alleviation and remained at levels similar to those of the STZ-group. Perhaps not enough β-cells had received protection by the pretreatment with the crude and the n-hexane extract of Nigella. The observations obtained from estimation of pancreatic GSH and pancreatic histology suggests partial alleviation of the pancreatic β-cells.
It can be concluded that pretreatment with Nigella sativa Linn. in STZ treated rats was beneficial in lowering the blood glucose concentrations, partial amelioration of the high lipids and partial elevation of the lowered pancreatic GSH concentrations of diabetic rats. Pancreatic histology has also suggested significant protection of pancreatic β cells following pretreatment of both crude and nhexane extract of Nigella sativa Linn. However, the crude Nigella pretreated group appears to have better protection. Future studies may be designed to characterize the ameliorating factors from the crude extract of Nigella and to determine the dose and duration of treatment by the ameliorating factor.
